These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2822752)
41. [Parvovirus infections in dermatology]. Schwarz TF; Roggendorf M Z Hautkr; 1989 Apr; 64(4):272-3. PubMed ID: 2544061 [TBL] [Abstract][Full Text] [Related]
42. Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard? Modrow S Ernst Schering Res Found Workshop; 2006; (55):63-82. PubMed ID: 16329658 [TBL] [Abstract][Full Text] [Related]
43. The clinical spectrum of human parvovirus B19 infections. Anderson LJ; Török TJ Curr Clin Top Infect Dis; 1991; 11():267-80. PubMed ID: 1651089 [No Abstract] [Full Text] [Related]
48. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. Cotmore SF; McKie VC; Anderson LJ; Astell CR; Tattersall P J Virol; 1986 Nov; 60(2):548-57. PubMed ID: 3021988 [TBL] [Abstract][Full Text] [Related]
49. Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations. Lefrère JJ; Couroucé AM; Bertrand Y; Girot R; Soulier JP Am J Hematol; 1986 Nov; 23(3):271-5. PubMed ID: 3020978 [TBL] [Abstract][Full Text] [Related]
50. Hematologic and hematopoietic consequences of B19 parvovirus infection. Young N Semin Hematol; 1988 Apr; 25(2):159-72. PubMed ID: 2838911 [TBL] [Abstract][Full Text] [Related]
51. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection. Samii K; Cassinotti P; de Freudenreich J; Gallopin Y; Le Fort D; Stalder H Clin Infect Dis; 1996 Jan; 22(1):162-4. PubMed ID: 8824988 [TBL] [Abstract][Full Text] [Related]
52. [Systemic manifestations of Parvovirus B19 infections]. Sève P; Ferry T; Charhon A; Calvet A; Broussolle C Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600 [TBL] [Abstract][Full Text] [Related]
53. Haematological consequences of parvovirus B19 infection. Brown KE Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):245-59. PubMed ID: 10942624 [TBL] [Abstract][Full Text] [Related]
54. Aplastic crisis and other effects of the human parvovirus infection. Blacklock HA; Mortimer PP Clin Haematol; 1984 Oct; 13(3):679-91. PubMed ID: 6094063 [TBL] [Abstract][Full Text] [Related]
55. [Parvovirus B19 as a cause of acute liver symptoms in adults]. Hillingsø JG; Jensen IP; Tom-Petersen L Ugeskr Laeger; 1998 Oct; 160(44):6355-6. PubMed ID: 9810242 [TBL] [Abstract][Full Text] [Related]
58. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. Gillespie SM; Cartter ML; Asch S; Rokos JB; Gary GW; Tsou CJ; Hall DB; Anderson LJ; Hurwitz ES JAMA; 1990 Apr; 263(15):2061-5. PubMed ID: 2157074 [TBL] [Abstract][Full Text] [Related]
59. [Parvovirus B19 infection--an insidious chameleon]. Broliden K; Tolfvenstam T; Papadogiannakis N; Westgren M; Matt P; Lundqvist A; Skjöldebrand-Sparre L; Nyman M; Henter JI Lakartidningen; 1999 Nov; 96(46):5066-9. PubMed ID: 10608130 [TBL] [Abstract][Full Text] [Related]
60. Human parvovirus B19 infection and antiphospholipid antibodies. von Landenberg P; Lehmann HW; Modrow S Autoimmun Rev; 2007 Apr; 6(5):278-85. PubMed ID: 17412298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]